[Featured Stock] MGen Solution, African Swine Fever Outbreak in Gangwon Province... Success in Developing Korea's First Resistant Pigs↑

MGeneSolution is showing strong performance following the domestic outbreak news of African Swine Fever (ASF). MGeneSolution has previously succeeded in developing pigs resistant to porcine epidemic diarrhea for the first time in Korea.

As of 10:09 AM on the 20th, MGeneSolution is trading at 2,905 KRW, up 4.68% compared to the previous day.

According to Gangwon Province on the 19th, African Swine Fever occurred in Cheorwon-gun. This is 52 days after the outbreak in Pocheon, Gyeonggi Province in April. To block horizontal transmission between farms, a temporary movement suspension order has been issued for 48 hours until midnight on the 20th for nine cities and counties including Cheorwon-gun and adjacent municipalities.

According to related industries, there have been cases where genes related to pig infection were replaced to treat African Swine Fever. In particular, researchers at the Roslin Institute in the UK are known to have succeeded in creating pigs resistant to viral diseases by manipulating genes using CRISPR-Cas9.

Meanwhile, MGeneSolution possesses third-generation CRISPR gene-editing technology. MGeneSolution was the first in Korea to successfully develop pigs resistant to porcine epidemic diarrhea and has obtained a patent for the method of producing porcine epidemic diarrhea-resistant pigs.

Additionally, the company has completed the development of a rapid in vitro diagnostic platform technology related to livestock infectious diseases and is reportedly in the process of obtaining product approval for a rapid on-site diagnostic kit for African Swine Fever (ASF).

A company representative explained, “The rapid molecular on-site diagnostic kit for African Swine Fever is a diagnostic method that allows simple and accurate diagnosis on-site with just one kit, without the need for expensive PCR diagnostic equipment.”